










Phosphorylation State-Specific GPCR Antibodies
Phosphorylation is the most important post-translational modification of G protein-coupled receptors (GPCRs). The lack of suitable tools has so far prevented examination of this important step in the GPCR activation / deactivation cycle. 7TM Antibodies® has already met this need for many GPCRs. It is our mission to provide Premium Phosphosite-Specific 7TM Antibodies for all relevant GPCR drug targets.

Immunohistochemistry-Grade GPCR Antibodies
GPCRs are notoriously difficult to detect in fixed tissues. We provide highly-characterized antibodies for selected human and rodent GPCRs that are well suited for efficient localization in formalin-fixed, paraffin-embedded tissues. GPCR antibodies at work!
About 7TM Antibodies
We are the exclusive manufacturer and provider of Premium Phosphosite-Specific 7TM Antibodies®. If you can not find antibodies for your GPCR target on our website, please check back later or contact us for more information. We strictly follow the IUPHAR guidelines for GPCR nomenclature.

Phosphorylation State-Specific GPCR Antibodies
Phosphorylation is the most important post-translational modification of G protein-coupled receptors (GPCRs). The lack of suitable tools has so far prevented examination of this important step in the GPCR activation / deactivation cycle. 7TM Antibodies® has already met this need for many GPCRs. It is our mission to provide Premium Phosphosite-Specific 7TM Antibodies for all relevant GPCR drug targets.

Immunohistochemistry-Grade GPCR Antibodies
GPCRs are notoriously difficult to detect in fixed tissues. We provide highly-characterized antibodies for selected human and rodent GPCRs that are well suited for efficient localization in formalin-fixed, paraffin-embedded tissues. GPCR antibodies at work!
About 7TM Antibodies
We are the exclusive manufacturer and provider of Premium Phosphosite-Specific 7TM Antibodies®. If you can not find antibodies for your GPCR target on our website, please check back later or contact us for more information. We strictly follow the IUPHAR guidelines for GPCR nomenclature.
µ-Receptor (MOP), N/OFQ Receptor (NOP) , ß2-Adrenoceptor (NEW)
CXCR4, ACKR3/CXCR7, CCR5 (NEW)
D2 Receptor, SST2 Somatostatin Receptor, D1 Receptor (NEW)
C5a1 Complement Receptor, C5a2 Complement Receptor
µ-Receptor (MOP), N/OFQ Receptor (NOP) , ß2-Adrenoceptor (NEW)
CXCR4, ACKR3/CXCR7, CCR5 (NEW)
D2 Receptor, SST2 Somatostatin Receptor, D1 Receptor (NEW)
C5a1 Complement Receptor, C5a2 Complement Receptor
µ-Receptor (MOP)
∂-Receptor (DOP)
κ-Receptor (KOP)
N/OFQ Receptor (NOP)
ß2-Adrenoceptor (NEW)
ACKR2
ACKR3/CXCR7
CXCR4
CCR5 (NEW)
CCR10 (NEW)
D1 Receptor (NEW)
D2 Receptor
SST2 Somatostatin Receptor
SST3 Somatostatin Receptor
SST5 Somatostatin Receptor
C5a1 Complement Receptor
C5a2 Complement Receptor
5HT4 (NEW)
P2Y4 (NEW)
P2Y12 (NEW)
µ-Receptor (MOP)
∂-Receptor (DOP)
κ-Receptor (KOP)
N/OFQ Receptor (NOP)
ß2-Adrenoceptor (NEW)
ACKR2
ACKR3/CXCR7
CXCR4
CCR5 (NEW)
CCR10 (NEW)
D1 Receptor (NEW)
D2 Receptor
SST2 Somatostatin Receptor
SST3 Somatostatin Receptor
SST5 Somatostatin Receptor
C5a1 Complement Receptor
C5a2 Complement Receptor
5HT4 (NEW)
P2Y4 (NEW)
P2Y12 (NEW)
Using 7TM Antibodies Website
If you would like to see your prices, shipping costs and taxes or create a customer account, request an offer or place an order, start by selecting your country of delivery below